Abstract
A variety of peptide ligands are known to inhibit the function of neuronal nicotinic acetylcholine receptors (nAChRs), including small toxins and brain-derived peptides such as β-amyloid1–42 and synthetic apolipoproteinE peptides. The myristoylated alanine-rich C kinase substrate (MARCKS) protein is a major substrate of protein kinase C and is highly expressed in the developing and adult brain. The ability of a 25-amino acid synthetic MARCKS peptide, derived from the effector domain (ED), to modulate nAChR activity was tested. To determine the effects of the MARCKS ED peptide on nAChR function, receptors were expressed in Xenopus laevis oocytes, and two-electrode voltage-clamp experiments were performed. The MARCKS ED peptide completely inhibited acetylcholine (ACh)-evoked responses from α7 nAChRs in a dose-dependent manner, yielding an IC50 value of 16 nM. Inhibition of ACh-induced responses was both activity- and voltage-independent. The MARCKS ED peptide was unable to block α-bungarotoxin binding. A MARCKS ED peptide in which four serine residues were replaced with aspartate residues was unable to inhibit α7 nAChR-mediated currents. The MARCKS ED peptide inhibited ACh-induced α4β2 and α2β2 responses, although with decreased potency. The effects of the MARCKS ED peptide on native nAChRs were tested using acutely isolated rat hippocampal slices. In hippocampal interneurons, the MARCKS ED peptide was able to block native α7 nAChRs in a dose-dependent manner. The MARCKS ED peptide represents a novel antagonist of neuronal nAChRs that has considerable utility as a research tool.
Footnotes
-
This study was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences.
-
The data presented here have appeared in abstract form as follows: Gay EA, Klein RC, Melton MA, Blackshear PJ, and Yakel JL (2007) Inhibition of native and recombinant nicotinic acetylcholine receptors by the myristoylated alanine-rich C kinase substrate peptide. In Program 574.15/J20. 2007 Neuroscience Meeting Planner; 2007 Nov 3–7; San Diego, CA. Society for Neuroscience, Washington, DC.
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.108.144758.
-
ABBREVIATIONS: nAChR, nicotinic ACh receptor; MARCKS, myristoylated alanine-rich C kinase substrate; PKC, protein kinase C; ED, effector domain; MLA, methyllycaconitine; α-BgTx, α-bungarotoxin; ACh, acetylcholine; CI, confidence interval.
- Received August 12, 2008.
- Accepted September 22, 2008.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|